Diabetes mellitus, especially type 2 diabetes mellitus (T2DM), has become a significant public health burden. (RC), known as , is widely used for treating diabetes in China. The bioactive compounds of RC, especially alkaloids, have the potential to suppress T2DM-induced lesions, including diabetic vascular dysfunction, diabetic heart disease, diabetic hyperlipidemia, diabetic nephropathy, diabetic encephalopathy, diabetic osteopathy, diabetic enteropathy, and diabetic retinopathy. This review summarizes the effects of RC and its bioactive compounds on T2DM and T2DM complications. Less research has been conducted on non-alkaloid fractions of RC, which may exert synergistic action with alkaloids. Moreover, we summarized the pharmacokinetic properties and structure-activity relationships of RC on T2DM with reference to extant literature and showed clearly that RC has potential therapeutic effect on T2DM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661542PMC
http://dx.doi.org/10.3389/fphar.2019.00805DOI Listing

Publication Analysis

Top Keywords

diabetes mellitus
12
type diabetes
8
bioactive compounds
8
diabetic
8
t2dm
5
potential treatment
4
treatment agent
4
agent type
4
diabetes
4
mellitus underlying
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!